Now that most people in North America and Europe are vaccinated and the COVID-19 pandemic is diminishing, Moderna is looking for its second act.
Tag Archive for: Moderna
Moderna is preparing for multiple product launches over the next several years, including RSV and flu vaccines and boosters for COVID-19. It is also aiming mRNA programs at rare diseases.
The United States is likely to start recommending COVID-19 vaccines annually, health officials said on Tuesday, as new boosters designed to fight currently circulating variants of the coronavirus roll out.
New COVID-19 boosters aimed at fighting currently circulating variants of the coronavirus will be widely available this week, U.S. health officials said on Tuesday, adding that the vaccine is moving closer to an annual jab, as with flu shots.
EU officials on Tuesday recommended that the two Omicron-tailored vaccines recently endorsed by the European Medicines Agency (EMA) be first deployed in high-risk individuals.
The European Union’s drug regulator on Thursday backed two separate COVID-19 vaccine boosters updated to target the Omicron variant, ahead of an anticipated rise in infections this winter.
Canada on Thursday authorized Moderna Inc.’s bivalent COVID-19 vaccine booster for people aged 18 and older, according to a notice posted on the government’s website.
Today, the agency amended the EUAs of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine to authorize bivalent formulations of the vaccines for use as a single booster dose at least two months following primary or booster vaccination.
Omicron-adapted vaccines will be delivered to the European Union within days of regulatory approval, European member of parliament Peter Liese said on Wednesday.
Moderna sued Pfizer and its German partner BioNTech on Friday for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic.
